Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
After removing patients with a previous diagnosis of gastroesophageal reflux, those prescribed GLP-1 RAs had a significantly increased risk for chronic cough compared with those prescribed any non-GLP-1 RA, DPP-4 inhibitor, SGLT2 inhibitor, or sulfonylurea (adjusted hazard ratios, 1.29, 1.36, 1.14, and 1.25, respectively)."This cohort study suggests that there is an association between GLP-1 receptor agonist use and new diagnosis of chronic cough," the authors write
Beckmann, M
While the 25 mg maintenance dose is the long-term target for chronic weight management, reaching it safely requires following the recommended 30-day dose escalation steps to help your body adjust and reduce gastrointestinal side effects
According to research published in the National Library of Medicine, this receptor activation suppresses appetite at the neurological level
